Small Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP4043040 (titled "Small Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by Glaxosmithkline on Aug 31, 2011. The application was issued on Jan 11, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSOct 11, 2023MEWBURN ELLIS
WEICKMANN & WEICKMANNOct 11, 2023-
HOPFNEROct 10, 2023-
SANOFIOct 9, 2023ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4043040

GLAXOSMITHKLINE
Application Number
EP22166818A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Dec 9, 2022
Publication Date
Jan 11, 2023